| Related Articles |
Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis.
Am J Cardiol. 2015 Dec 31;
Authors: Mostafa A, Briasoulis A, Telila T, Belgrave K, Grines C
Abstract
The presentation of acute pulmonary thromboembolism (PE) can be highly variable resulting in diagnostic challenges and management difficulties. Current guidelines suggest that therapy must be adjusted based on the severity of PE presentation. Systemic thrombolysis is the standard therapy for acute massive PE; however, systemic thrombolysis carries an estimated 20% risk of major hemorrhage, including a 3% to 5% risk of hemorrhagic stroke. There are data supporting the use of catheter-directed therapy (CDT) in massive and submassive PE, but past studies have limited its use to patients in whom systemic thrombolysis has either failed or was contraindicated. There is a paucity of data comparing the efficacy of CDT compared to systemic thrombolysis in different risk groups. This review will summarize the available data on the techniques and indications and outcomes of CDT for acute PE.
PMID: 26833207 [PubMed - as supplied by publisher]